We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+15.08%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$2.54B
AUM Growth
+$43.1M
Cap. Flow
-$177M
Cap. Flow %
-6.95%
Top 10 Hldgs %
27.59%
Holding
204
New
24
Increased
56
Reduced
107
Closed
17

Top Buys

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$23.2M
2
QXO
QXO Inc
QXO
+$19.2M
3
ACVA icon
ACV Auctions
ACVA
+$16.6M
4
HUBS icon
HubSpot
HUBS
+$14.5M
5
KRUS icon
Kura Sushi USA
KRUS
+$13.8M

Top Sells

Rank Stock Value
1
ZETA icon
Zeta Global
ZETA
+$66.7M
2
SPT icon
Sprout Social
SPT
+$21.9M
3
ARRY icon
Array Technologies
ARRY
+$17.5M
4
SMAR
Smartsheet Inc.
SMAR
+$17.2M
5
MGNI icon
Magnite
MGNI
+$16.8M

Sector Composition

Rank Sector Weight
1 Technology 32.68%
2 Healthcare 22.32%
3 Industrials 15.46%
4 Consumer Discretionary 8.56%
5 Communication Services 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITCI
101
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$7.28M 0.29%
99,534
+6,949
+8% +$522K
MEC icon
102
Mayville Engineering Co
MEC
$580M
$7.13M 0.28%
338,215
+13,781
+4% +$258K
TXG icon
103
10x Genomics
TXG
$7.77B
$7.11M 0.28%
315,054
-18,953
-6% -$392K
RVMD icon
104
Revolution Medicines
RVMD
$44.1B
$6.77M 0.27%
+149,359
New +$6.5M
SLAB icon
105
Silicon Laboratories
SLAB
$7.2B
$6.77M 0.27%
58,593
+22,418
+62% +$2.5M
BLBD icon
106
Blue Bird Corp
BLBD
$2.1B
$6.76M 0.27%
141,037
+128
+0.1% +$6.32K
CCC
107
CCC Intelligent Solutions
CCC
$4.02B
$6.72M 0.26%
607,986
-213,106
-26% -$2.3M
AGIO icon
108
Agios Pharmaceuticals
AGIO
$1.97B
$6.7M 0.26%
150,785
+13,947
+10% +$633K
ALGM icon
109
Allegro MicroSystems
ALGM
$7.95B
$6.6M 0.26%
283,275
+63,871
+29% +$1.61M
RXST icon
110
RxSight
RXST
$281M
$5.93M 0.23%
120,046
+25,955
+28% +$1.33M
MLAB icon
111
Mesa Laboratories
MLAB
$614M
$5.93M 0.23%
45,633
-8,791
-16% -$1.03M
BOOT icon
112
Boot Barn
BOOT
$5.09B
$5.86M 0.23%
35,021
+1,416
+4% +$195K
FIVN icon
113
FIVE9
FIVN
$2.49B
$5.85M 0.23%
203,446
-83,684
-29% -$3.02M
LEGN icon
114
Legend Biotech
LEGN
$4.22B
$5.83M 0.23%
+119,591
New +$6.37M
NTLA icon
115
Intellia Therapeutics
NTLA
$1.69B
$5.83M 0.23%
283,534
+68,624
+32% +$1.58M
CYTK icon
116
Cytokinetics
CYTK
$10.8B
$5.75M 0.23%
108,957
-27,921
-20% -$1.56M
DSGX icon
117
Descartes Systems
DSGX
$6.82B
$5.67M 0.22%
55,113
-10,560
-16% -$1.05M
MRUS
118
DELISTED
Merus
MRUS
$5.66M 0.22%
113,251
+92,976
+459% +$4.85M
INFA
119
DELISTED
Informatica
INFA
$5.54M 0.22%
+218,977
New +$5.55M
RCUS icon
120
Arcus Biosciences
RCUS
$3.69B
$5.47M 0.22%
357,838
-22,009
-6% -$347K
APGE icon
121
Apogee Therapeutics
APGE
$10.2B
$5.39M 0.21%
+91,757
New +$4.4M
IRTC icon
122
iRhythm Holdings
IRTC
$4.04B
$5.38M 0.21%
+72,428
New +$5.77M
PRTA icon
123
Prothena Corp
PRTA
$472M
$5.23M 0.21%
312,520
-23,140
-7% -$498K
EXLS icon
124
EXL Service
EXLS
$5.3B
$5.16M 0.2%
135,222
-61,434
-31% -$2.15M
NOVT icon
125
Novanta
NOVT
$6.27B
$5.14M 0.2%
28,746
+8,315
+41% +$1.45M
3 4
5
6 7

Similar funds

BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return

Granahan Investment Management's Q3 2024 Portfolio in Review

As of Q3 2024, Granahan Investment Management held 204 positions worth $2.54B, up 1.7% from $2.5B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Granahan Investment Management withdrew a net $177M in Q3 2024, closing 17 positions and reducing 107 holdings. Its most notable exit was Azenta, an estimated $7.63M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 40% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Granahan Investment Management opened a new position in Exact Sciences worth $27.9M.

  • Granahan Investment Management's largest Q3 2024 buy was Exact Sciences: 410,241 shares worth $27.9M.
  • Granahan Investment Management added most to ACV Auctions in Q3 2024, an estimated $16.6M increase.
  • Granahan Investment Management's biggest Q3 2024 reduction was Zeta Global, cutting an estimated $66.7M.
  • Granahan Investment Management fully exited Azenta in Q3 2024, selling an estimated $7.63M.
  • Granahan Investment Management's ten largest holdings make up 28% of its $2.54B portfolio in Q3 2024.
  • Granahan Investment Management opened 24 new positions and closed 17 in Q3 2024.
  • Granahan Investment Management's portfolio value rose 1.7% quarter-over-quarter to $2.54B.

Based on Granahan Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.